We have located links that may give you full text access.
Anticholinergic Drug Induced Cognitive and Physical Impairment: Results from the InCHIANTI Study.
Background: The aims of this study were to evaluate the relationship between anticholinergic drug burden (ACB) cognitive impairment, physical frailty and cognitive frailty, and determine if ACB is predictive of these phenotypes when modeled with biological and genomic biomarkers.
Methods: In a retrospective cohort study, a total of 1,453 adults aged 20-102 years was used to examine ACB as a predictor for cognitive impairment, physical frailty, and cognitive frailty. Anticholinergic burden is examined as a predictor for all phenotypes in a cross-sectional analysis using logistic, ordinal regression models, and Extreme Gradient Boosting for population predictive modeling.
Results: A significant association was found between ACB and cognitive decline (p = 0.02), frailty (p <.001) and cognitive frailty (p <.001). The odds of cognitive impairment increased by 1.21 (95% CI = 1.06-1.37, p <.001), odds of being frail increased by 1.33 (95% CI = 1.18-1.50, p <.001), and odds of having cognitive frailty increased by 1.36 (95% CI = 1.21-1.54, p <.001). Population modeling results indicated ACB score as one of the stronger predictors for cognitive impairment, physical frailty, and cognitive frailty with AUCs ranging from 0.81-0.88.
Conclusions: Anticholinergic medications are a potentially modifiable risk factor for the prevention of cognitive and physical decline. Identification of reversible causes for cognitive and physical impairment is critical for the aging population. These findings encourage new research that may lead to effective interventions for deprescribing programs for the prevention of cognitive and physical decline in older adults.
Methods: In a retrospective cohort study, a total of 1,453 adults aged 20-102 years was used to examine ACB as a predictor for cognitive impairment, physical frailty, and cognitive frailty. Anticholinergic burden is examined as a predictor for all phenotypes in a cross-sectional analysis using logistic, ordinal regression models, and Extreme Gradient Boosting for population predictive modeling.
Results: A significant association was found between ACB and cognitive decline (p = 0.02), frailty (p <.001) and cognitive frailty (p <.001). The odds of cognitive impairment increased by 1.21 (95% CI = 1.06-1.37, p <.001), odds of being frail increased by 1.33 (95% CI = 1.18-1.50, p <.001), and odds of having cognitive frailty increased by 1.36 (95% CI = 1.21-1.54, p <.001). Population modeling results indicated ACB score as one of the stronger predictors for cognitive impairment, physical frailty, and cognitive frailty with AUCs ranging from 0.81-0.88.
Conclusions: Anticholinergic medications are a potentially modifiable risk factor for the prevention of cognitive and physical decline. Identification of reversible causes for cognitive and physical impairment is critical for the aging population. These findings encourage new research that may lead to effective interventions for deprescribing programs for the prevention of cognitive and physical decline in older adults.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app